338 related articles for article (PubMed ID: 20613975)
1. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.
Hess D; Chisholm JW; Igal RA
PLoS One; 2010 Jun; 5(6):e11394. PubMed ID: 20613975
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK.
Scaglia N; Chisholm JW; Igal RA
PLoS One; 2009 Aug; 4(8):e6812. PubMed ID: 19710915
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells.
Minville-Walz M; Pierre AS; Pichon L; Bellenger S; Fèvre C; Bellenger J; Tessier C; Narce M; Rialland M
PLoS One; 2010 Dec; 5(12):e14363. PubMed ID: 21179554
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
Nashed M; Chisholm JW; Igal RA
Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.
Huang Q; Wang Q; Li D; Wei X; Jia Y; Zhang Z; Ai B; Cao X; Guo T; Liao Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):129. PubMed ID: 30876460
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
9. Exogenous lipids promote the growth of breast cancer cells via CD36.
Zhao J; Zhi Z; Wang C; Xing H; Song G; Yu X; Zhu Y; Wang X; Zhang X; Di Y
Oncol Rep; 2017 Oct; 38(4):2105-2115. PubMed ID: 28765876
[TBL] [Abstract][Full Text] [Related]
10. Inducing effect of clofibric acid on stearoyl-CoA desaturase in intestinal mucosa of rats.
Yamazaki T; Kadokura M; Mutoh Y; Sakamoto T; Okazaki M; Mitsumoto A; Kawashima Y; Kudo N
Lipids; 2014 Dec; 49(12):1203-14. PubMed ID: 25362535
[TBL] [Abstract][Full Text] [Related]
11. EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer.
Zhang J; Song F; Zhao X; Jiang H; Wu X; Wang B; Zhou M; Tian M; Shi B; Wang H; Jia Y; Wang H; Pan X; Li Z
Mol Cancer; 2017 Jul; 16(1):127. PubMed ID: 28724430
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.
Nishizawa S; Sumi H; Satoh Y; Yamamoto Y; Kitazawa S; Honda K; Araki H; Kakoi K; Imamura K; Sasaki M; Miyahisa I; Satomi Y; Nishigaki R; Hirayama M; Aoyama K; Maezaki H; Hara T
Eur J Pharmacol; 2017 Jul; 807():21-31. PubMed ID: 28442322
[TBL] [Abstract][Full Text] [Related]
14. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids.
Mason P; Liang B; Li L; Fremgen T; Murphy E; Quinn A; Madden SL; Biemann HP; Wang B; Cohen A; Komarnitsky S; Jancsics K; Hirth B; Cooper CG; Lee E; Wilson S; Krumbholz R; Schmid S; Xiang Y; Booker M; Lillie J; Carter K
PLoS One; 2012; 7(3):e33823. PubMed ID: 22457791
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.
Pisanu ME; Noto A; De Vitis C; Morrone S; Scognamiglio G; Botti G; Venuta F; Diso D; Jakopin Z; Padula F; Ricci A; Mariotta S; Giovagnoli MR; Giarnieri E; Amelio I; Agostini M; Melino G; Ciliberto G; Mancini R
Cancer Lett; 2017 Oct; 406():93-104. PubMed ID: 28797843
[TBL] [Abstract][Full Text] [Related]
16. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.
Igal RA
Carcinogenesis; 2010 Sep; 31(9):1509-15. PubMed ID: 20595235
[TBL] [Abstract][Full Text] [Related]
17. Scd1 mammary-specific vector constructed and overexpressed in goat fibroblast cells resulting in an increase of palmitoleic acid and oleic acid.
Wang L; You J; Zhong B; Ren C; Zhang Y; Li M; Zhang G; Jia R; Ying S; Wang F
Biochem Biophys Res Commun; 2014 Jan; 443(2):389-94. PubMed ID: 24309099
[TBL] [Abstract][Full Text] [Related]
18. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells.
Scaglia N; Igal RA
J Biol Chem; 2005 Jul; 280(27):25339-49. PubMed ID: 15851470
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins.
Rios-Esteves J; Resh MD
Cell Rep; 2013 Sep; 4(6):1072-81. PubMed ID: 24055053
[TBL] [Abstract][Full Text] [Related]
20. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
